RTW INVESTMENTS, LP
Institutional investor · Portfolio as of Q4 2019
Top Holdings61 positions
ROCKET PHARMACEUTICALS INC | 16.8M | $382.7M | 14.4% | $17.53 | +31.88% | 4 qtrssince 2019-Q1 | Increased 61 |
ALNYLAM PHARMACEUTICALS INC | 1.6M | $188.6M | 7.1% | $80.50 | +42.47% | 4 qtrssince 2019-Q1 | Decreased 0 |
PTC THERAPEUTICS INC | 3.8M | $184.1M | 6.9% | $38.90 | +22.24% | 4 qtrssince 2019-Q1 | Increased 62 |
DICERNA PHARMACEUTICALS INC | 5.9M | $129.4M | 4.9% | — | — | 4 qtrssince 2019-Q1 | Decreased 0 |
AXSOME THERAPEUTICS INC | 1M | $106.1M | 4.0% | $32.80 | +216.55% | 4 qtrssince 2019-Q1 | Increased 66 |
BRISTOL MYERS SQUIBBCO | 1.6M | $105.5M | 4.0% | $37.30 | +34.81% | 4 qtrssince 2019-Q1 | Increased 58 |
STOKE THERAPEUTICS INC | 3.5M | $100.4M | 3.8% | $29.08 | -5.24% | 3 qtrssince 2019-Q2 | Increased 58 |
| 4.3M | $90M | 3.4% | — | — | 4 qtrssince 2019-Q1 | Increased 83 | |
MIRATI THERAPEUTICS INC | 645,427 | $83.2M | 3.1% | — | — | 4 qtrssince 2019-Q1 | Increased 60 |
SAREPTA THERAPEUTICS INC | 605,762 | $78.2M | 2.9% | $123.90 | +3.95% | 4 qtrssince 2019-Q1 | Decreased 0 |
ADVERUM BIOTECHNOLOGIES INC | 6.4M | $73.6M | 2.8% | $54.05 | +107.60% | 4 qtrssince 2019-Q1 | Increased 52 |
IMMUNOVANT INC | 4.4M | $66M | 2.5% | $15.81 | 0.00% | 1 qtr | New 76 |
ZIMMER BIOMET HOLDINGS INC | 437,385 | $65.5M | 2.5% | $124.90 | +10.11% | 2 qtrssince 2019-Q3 | Increased 55 |
MILESTONE PHARMACEUTICALS IN | 4M | $63.4M | 2.4% | $25.87 | -39.97% | 3 qtrssince 2019-Q2 | Increased 57 |
MASIMO CORP | 382,187 | $60.4M | 2.3% | $139.11 | +14.01% | 4 qtrssince 2019-Q1 | Increased 52 |
ESTABLISHMENT LABS HLDGS INC | 2M | $56.2M | 2.1% | $23.06 | +17.74% | 4 qtrssince 2019-Q1 | Decreased 0 |
MYOKARDIA INC | 760,988 | $55.5M | 2.1% | — | — | 4 qtrssince 2019-Q1 | Increased 53 |
VERICEL CORP | 3M | $52M | 2.0% | $17.50 | -1.44% | 4 qtrssince 2019-Q1 | Increased 52 |
PROQR THRAPEUTICS N V | 4.8M | $47.4M | 1.8% | $12.87 | -26.59% | 4 qtrssince 2019-Q1 | Increased 58 |
AXONICS INC | 1.6M | $44.1M | 1.7% | — | — | 4 qtrssince 2019-Q1 | Increased 48 |
RTW INVESTMENTS, LP manages $2.7B across 61 positions as of Q4 2019. Top holdings: RCKT (14.4%), ALNY (7.1%), PTCT (6.9%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3.5/5.0.
Active quarter - 13 new positions, 12 exits, 31 increased. Top move: IMVT (NEW, conviction 76). Portfolio: $2.7B across 61 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR